Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatatsvir in People who inject drugs and/or those in Opioid Agonist Therapy
2018| Hepatitis Communications |Available Online

Contextualizing Canada's Hepatitis C Virus Epidemic
2018| Canadian Liver Journal | Available Online

Applying core theory and spatial analysis to identify HCV infection 'core areas' in British Columbia, Canada
2018| Journal of Viral Hepatitis | Available Online

Effect of  opioid subistution therapy (OST) and psychotherapy on HIV risk among HCV infected individuals
2018| Clinical Epidemiology | Available Online

Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.
2018| Journal of Viral Hepatitis | Available Online

Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based cohort study
2018| E Clinical Medicine | Available Online

Real-world effectiveness of sofosbuvir-based regimens for Hepatitis C treatment among people who inject drugs and/or those in opioid substitution therapy in Canada
2018| Hepatology Communications |In Press

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy on a large population based cohort
2018| Journal of Hepatology | Available Online | Lay Summary

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
2018| World Journal of Gastroenterology| Available Online| Lay Summary

Identifying Injection Drug Use and Estimating Population size of people who inject drugs using healthcare administrative datasets
2018| International Journal of Drug Policy| Available Online

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison
2018|Journal of Viral Hepatitis| Available Online

The contribution of alcohol-use to decompensated cirrhosis among people with hepatitis C: an international study
2017| Journal of Hepatology| Available Online

A Syndemic Approach to assess the effect of Substance Use and Social Disparities’ on the evolution of HIV/HCV infections in British Columbia. 
2017| PLOS ONE| Available Online| Lay Summary

Hepatitis C cross-genotype immunity and implications for vaccine development.
2017|Scientific Report|Available Online

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development
2017|Journal of Hepatology| Available Online | Lay Summary

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study
2017|The Lancet Gastroenterology & Hepatology| Available Online

Assessing hepatitis C burden and treatment effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): design and characteristics of linked and unlinked participants.
2016|PLOS ONE| Available Online

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis
Testers Cohort.
2016| BMC Infectious Diseases| Available Online

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
2016|Ebiomedicine| Available Online

Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
2016|Journal of Hepatology| Available Online

Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort. 
2016|Journal of Viral Hepatology| Available Online

Shift in disparities in Hepatitis C treatment form interferon to DAA: A population-based cohort study.
2016| Journal of Viral Hepatology| Available Online